Latest market price
18.64
+0.79+4.40%
OverviewShort InterestFilings
RCUSQT20Arcus Biosciences, Inc.·NYSE
18.64+4.40%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 23, 20268-KCurrent report
Oct 22, 2026424B5Prospectus
Oct 21, 20268-KCurrent report
Oct 21, 2026424B5Prospectus
Oct 20, 20268-KCurrent report
Sep 28, 2026CT ORDERConfidential treatment order
Aug 24, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 05, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 13, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 01, 20264Statement of changes in beneficial ownership
May 12, 20264Statement of changes in beneficial ownership
May 12, 20264Statement of changes in beneficial ownership
May 05, 202610-QQuarterly report
#1 / 25 of 328
Page
▼
/ 14